Neospora caninum peroxiredoxin 1 is an essential virulence effector with antioxidant function
Article in Veterinary Parasitology (January 2024)
The most recent citing publications are shown below. View all 28 publications that cite this research output on Dimensions.
Exploiting the Macrophage Production of IL-12 in Improvement of Vaccine Development against Toxoplasma gondii and Neospora caninum Infections
Article in Vaccines (December 2022)
Research progress of recombinant thioredoxin peroxidase of important human parasites involved in immunoregulation, immunodiagnosis and immunoprophylaxis
Article in Chinese Journal of Endemiology (October 2022)